Le Lézard
Classified in: Science and technology
Subject: PDT

Internationally Acclaimed, Expressionist Painter & Cardano Mega Supporter, Louie Rochon, Announces ADA Payment


CLINTON, Wash., March 5, 2021 /PRNewswire/ -- "I paint for the sheer love of painting. It's that simple, It brings me great joy and happiness not only in the creation but especially in sharing my work with others. Of course I need to make a living but if I were to approach my paintings with that in mind, I might as well as quit as my work would be garbage! It would be empty, meaningless and void of any soul or purpose.

This is why I am so firmly dedicated to Charles and the Cardano project. Never has he approached this work from the intention of the almighty $. His only concern, ever, was how to create a level playing field, for all people, especially underdeveloped countries, something Cardano is superbly suited for! How to help 'people!' I love this about him. He is the real deal. SO rare these days! Cardano is deeply researched. It's time has come and ... I'm all in!"

Rochon's work has been honored for the past four years in prestigious International Art competitions. See image of recent winner, 'Ovation;' 'International Artists' Magazine and 'American Art Collector' Magazine, 1/21.

"I'm getting older now but as long as I can drag myself down to the studio, roll around in some paint (I get really dirty) and can get positive, hopeful paintings out into the world, well, that makes me pretty happy. There's more than enough negativity out there. This is my small contribution; BIG, Bright and BOLD Color!"

Website: www.rochonfineart.com

Gallery: www.artworkarchive.com/profile/rochon-fine-art

Press Contact:

Louie Rochon
360 982-8170
https://www.rochonfineart.com

SOURCE Rochon Fine Art


These press releases may also interest you

at 18:00
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plustm, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:50
Cantaloupe, Inc. to Report Third Quarter Fiscal Year 2024 Results on May 9, 2024
Cantaloupe, Inc. , a leading provider of end-to-end technology solutions for self-service commerce, today announced that management will host a webcast to discuss its financial results for the third quarter of fiscal year 2024 on Thursday, May 9,...

at 17:31
DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...

at 17:21
TRAM VF Announces Flagship Investment in London Ride-Hailing Startup, OUNO
Tri Ri Asset Management ("TRAM") is pleased to announce a strategic investment from its flagship venture capital fund, the TRAM Venture Fund ("TRAM VF"), in OUNO, a pioneering executive ride-hailing platform headquartered in London. This...

at 17:20
Melanie McFaddin with Wiley Bros ? Aintree Capital &Partners, LLC Represents Theoris, Inc. in its Acquisition by CoreTech Consulting Group, LLC
Melanie McFaddin, representative of Wiley Bros ? Aintree Capital &Partners, LLC ("WBAC") is pleased to announce its representation of Theoris, Inc. ("Theoris" and the "Company") in its sale to CoreTech Consulting Group, LLC ("CoreTech"). Theoris'...

at 17:16
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Sharecare Inc. to Contact Law Firm
Moore Law, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against: Sharecare...

More news about Science and technology...


News published on and distributed by: